Literature DB >> 11354269

Preventing adverse sequelae of bacterial vaginosis: a public health program and research agenda.

E H Koumans1, J S Kendrick.   

Abstract

BACKGROUND: The cause of bacterial vaginosis remains poorly understood. Recent evidence strengthens the association between bacterial vaginosis and serious medical complications. GOAL: To review the evidence linking bacterial vaginosis with adverse pregnancy outcomes, complications after gynecologic procedures, and HIV infection, and to identify prevention strategies.
METHODS: In March 1999, the Centers for Disease Control and Prevention organized a conference to accomplish this goal.
RESULTS: Better understanding is needed concerning the etiology, epidemiology, and natural history of bacterial vaginosis. More efficacious treatment of bacterial vaginosis and strategies to reduce maternal complications associated with bacterial vaginosis, such as premature rupture of the fetal membranes, chorioamnionitis, premature labor and delivery, postdelivery endometritis, and postpartum infant complications should be developed. Recent evidence shows that screening and treatment of bacterial vaginosis before abortion reduces postabortion pelvic inflammatory disease, and that anaerobic coverage during hysterectomy reduces postoperative complications. Better understanding concerning the relation of bacterial vaginosis to acquisition of sexually transmitted diseases and HIV infection are needed as well as possible prevention strategies.
CONCLUSIONS: A national prevention effort should be guided by the results of research that addresses current knowledge gaps.

Entities:  

Mesh:

Year:  2001        PMID: 11354269     DOI: 10.1097/00007435-200105000-00011

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  36 in total

1.  Prevalence of bacterial vaginosis and Candida among postmenopausal women in the United States.

Authors:  Joscelyn N Hoffmann; Hannah M You; E C Hedberg; Jeanne A Jordan; Martha K McClintock
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2014-11       Impact factor: 4.077

2.  Can known risk factors explain racial differences in the occurrence of bacterial vaginosis?

Authors:  Roberta B Ness; Sharon Hillier; Holly E Richter; David E Soper; Carol Stamm; Debra C Bass; Richard L Sweet; Peter Rice
Journal:  J Natl Med Assoc       Date:  2003-03       Impact factor: 1.798

Review 3.  Bacterial vaginosis: more questions than answers.

Authors:  Erica Weir
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

4.  The vaginal microbiome in health and disease.

Authors:  Bryan A White; Douglas J Creedon; Karen E Nelson; Brenda A Wilson
Journal:  Trends Endocrinol Metab       Date:  2011-07-13       Impact factor: 12.015

5.  Racial differences in cervical cytokine concentrations between pregnant women with and without bacterial vaginosis.

Authors:  Kelli K Ryckman; Scott M Williams; Marijane A Krohn; Hyagriv N Simhan
Journal:  J Reprod Immunol       Date:  2008-03-11       Impact factor: 4.054

6.  Bacterial vaginosis is associated with variation in dietary indices.

Authors:  Marie E Thoma; Mark A Klebanoff; Alisha J Rovner; Tonja R Nansel; Yasmin Neggers; William W Andrews; Jane R Schwebke
Journal:  J Nutr       Date:  2011-07-06       Impact factor: 4.798

7.  Relative performance of three methods for diagnosing bacterial vaginosis during pregnancy.

Authors:  Vijaya K Hogan; Jennifer F Culhane; Jane Hitti; Virginia A Rauh; Kelly F McCollum; Kathy J Agnew
Journal:  Matern Child Health J       Date:  2007-09-15

8.  Evaluation of a point-of-care test, BVBlue, and clinical and laboratory criteria for diagnosis of bacterial vaginosis.

Authors:  C S Bradshaw; A N Morton; S M Garland; L B Horvath; I Kuzevska; C K Fairley
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

9.  The laboratory diagnosis of bacterial vaginosis.

Authors:  Deborah Money
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-03       Impact factor: 2.471

10.  Purification and characterization of enterocin 62-6, a two-peptide bacteriocin produced by a vaginal strain of Enterococcus faecium: Potential significance in bacterial vaginosis.

Authors:  Diane C Dezwaan; Michael J Mequio; Julia S Littell; Jonathan P Allen; Silvia Rossbach; Vivien Pybus
Journal:  Microb Ecol Health Dis       Date:  2007-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.